Company

Yet again a successful business year for EUROIMMUN

2015 was yet again a very satisfying year for EUROIMMUN, as announced at the Annual Meeting of Shareholders on 8 July 2016. This year, around 750 shareholders assisted the meeting, which is a new record. With an increase of 17.5%, the Group turnover exceeded the threshold of 200 million euros for the first time (amounting […]

Science

EUVAS study confirms efficiency of automated multiparametric immunofluorescene for detection of vasculitis-associated ANCA

Scientist of the European Vasculitis Study (EUVAS) group published the results of a recent study (Csernok et al., Autoimmunity Reviews 2016) testing the performance of two fully automated platforms for multiparametric ANCA IIFT diagnostics which combine cell substrates and monospecific antigen substrates: the EUROPLUS Granulocyte Mosaic (EUROPattern, Euroimmun AG) and CytoBead ANCA (Aklides, Medipan/Generic Assays

Scroll to Top